ME Therapeutics has entered into a technology license agreement with the National Research Council of Canada to license a ...

HCW Biologics Inc. (the “Company”) (NASDAQ: HCWB), a U.S.-based clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies to extend healthspan by ...